Reversing type 2 diabetes: pancreas composition and function during return to normal glucose tolerance



Similar documents
Type 2 Diabetes and Prediabetes: A New Understanding of Cause and Treatment. Bruce Latham, M.D. Endocrine Specialists Greenville Health System

Diabetes and Obesity in Children. Janie Berquist, RN, BSN, MPH, CDE Children s Mercy Hospitals and Clinics Kansas City, MO

1. PATHOPHYSIOLOGY OF METABOLIC SYNDROME

PowerPoint Lecture Outlines prepared by Dr. Lana Zinger, QCC CUNY. 12a. FOCUS ON Your Risk for Diabetes. Copyright 2011 Pearson Education, Inc.

Diabetes mellitus is a chronic condition that occurs as a result of problems with the production and/or action of insulin in the body.

Body Composition & Longevity. Ohan Karatoprak, MD, AAFP Clinical Assistant Professor, UMDNJ

Sponsor. Novartis Generic Drug Name. Vildagliptin. Therapeutic Area of Trial. Type 2 diabetes. Approved Indication. Investigational.

INSULIN AND INCRETIN THERAPIES: WHAT COMBINATIONS ARE RIGHT FOR YOUR PATIENT?

Prevention of and the Screening for Diabetes Part I Insulin Resistance By James L. Holly, MD Your Life Your Health The Examiner January 19, 2012

Diabetes and Obesity. The diabesity epidemic

Homeostatic Model Assessment (HOMA)

BARIATRIC SURGERY MAY CURE TYPE 2 DIABETES IN SOME PATIENTS

Introduction. Pathogenesis of type 2 diabetes

DIET AND EXERCISE STRATEGIES FOR WEIGHT LOSS AND WEIGHT MAINTENANCE

Weight Loss Surgery and Bariatric Nutrition. Jeanine Giordano, MS, RD, CDN

Diabetes mellitus. Lecture Outline

DR. Trinh Thi Kim Hue

Pathophysiology of Type 2 Diabetes and Its Treatment Policy

Nutrition Therapy in Diabetes Mellitus. Dorothy Debrah Diabetes Specialist Dietitian University Hospital, Llandough. Wales, UK February 2012

TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION. Robert Dobbins, M.D. Ph.D.

I nthis clinical contribution to the

Department Of Biochemistry. Subject: Diabetes Mellitus. Supervisor: Dr.Hazim Allawi & Dr.Omar Akram Prepared by : Shahad Ismael. 2 nd stage.

Type 2 Diabetes Mellitus and Insulin resistance syndrome in Children

Am I at Risk for type 2 Diabetes? Taking Steps to Lower the Risk of Getting Diabetes NATIONAL DIABETES INFORMATION CLEARINGHOUSE

Treatment for Severely Obese Patients

Distinguishing between Diabetes Mellitus Type 1 and Type 2, (with Overview of Treatment Strategies)

Role of Body Weight Reduction in Obesity-Associated Co-Morbidities

The Arguments: T2DM - tremendous economic burden globally Lifestyle / Pharm Rx:

Long term Weight Management in Obese Diabetic Patients Osama Hamdy, MD, PhD, FACE

Calculating and Graphing Glucose, Insulin, and GFR HASPI Medical Biology Activity 19c

CME Test for AMDA Clinical Practice Guideline. Diabetes Mellitus

Overview of Diabetes Management. By Cindy Daversa, M.S.,R.D.,C.D.E. UCI Health

Published Quarterly Mangalore, South India ISSN Volume 4, Issue 1; January-March 2005

How To Lose Weight With Diabetes

Is Insulin Effecting Your Weight Loss and Your Health?

WHAT IS DIABETES MELLITUS? CAUSES AND CONSEQUENCES. Living your life as normal as possible

Cardiovascular Disease Risk Factors Part XII Insulin Resistance By James L. Holly, MD Your Life Your Health The Examiner September 15, 2005

YOUR LAST DIET IDEAL PROTEIN

DIABETES AND INSULIN RESISTANCE DIABETES PREVALANCE

Sugars and Health: Are we winning the battle, but losing the war Sugars and Insulin Resistance

Effects of macronutrients on insulin resistance and insulin requirements

Family History and Diabetes. Practical Genomics for the Public Health Professional

Statins and Risk for Diabetes Mellitus. Background

Insulin or GLP1 How to make this choice in Practice. Tara Kadis Lead Nurse - Diabetes & Endocrinology Mid Yorkshire Hospitals NHS Trust

Preservation and Incorporation of Valuable Endoscopic Innovations (PIVI)

Diabetes and Stroke. Understanding the connection between diabetes and the increased risk of stroke

Dealing with weight regain after Rouxen-Y gastric bypass: surgical approach

The first endoscopically-delivered device therapy for obese patients with type 2 diabetes

嘉 義 長 庚 醫 院 藥 劑 科 Speaker : 翁 玟 雯

Sudbury Bariatric Regional Assessment & Treatment Centre

What is Type 2 Diabetes?

Comparative Studies and Metabolic Effects of Sleeve Gastrectomy

The South Asian Indian Women s s Weight Loss Study. Latha Palaniappan, MD, MS BIRCWH Scholar October 20, 2005

Regulation of Metabolism. By Dr. Carmen Rexach Physiology Mt San Antonio College

Overview of Metabolism. Peds 231 April 9, 2009 Julie Theriot

Protein Intake in Potentially Insulin Resistant Adults: Impact on Glycemic and Lipoprotein Profiles - NPB #01-075

New and Future Treatments for Diabetes. Mary Charlton Specialty Doctor in Diabetes University Hospital Birmingham BARS Oct 2014

Insulin Resistance and Prediabetes

You are a doctor at a busy general practice surgery in the city suburbs.

Section 2. Overview of Obesity, Weight Loss, and Bariatric Surgery

TYPE 2 DIABETES IN CHILDREN DIAGNOSIS AND THERAPY. Ines Guttmann- Bauman MD Clinical Associate Professor, Division of Pediatric Endocrinology, OHSU

DIABETES MELLITUS. By Tracey Steenkamp Biokineticist at the Institute for Sport Research, University of Pretoria

Primary Care Guidance Program: Non-Alcohol related Fatty Liver Disease (NAFLD) Guidance on Management in Primary Care

Phil. J. Internal Medicine, 47: 25-30, Jan.-Feb., 2009

Treating Patients with PRE-DIABETES David Doriguzzi, PA-C First Valley Medical Group. Learning Objectives. Background. CAPA 2015 Annual Conference

PREOPERATIVE MANAGEMENT FOR BARIATRIC PATIENTS. Adrienne R. Gomez, MD Bariatric Physician St. Vincent Bariatric Center of Excellence

Sedentarity and Exercise in the Canadian Population. Angelo Tremblay Division of kinesiology

Catholic Medical Center & Androscoggin Valley Hospital. Surgical Weight Loss Options For a Healthier Tomorrow

Beating insulin resistance through lifestyle changes

Delayed effects from past high-level exposures in a fishing community: Type 2 diabetes in septuagenarians

Overview and update of modern type 2 Diabetes philosophy and management. Dr Steve Stanaway Consultant Endocrinologist BCU

WHAT DOES DYSMETABOLIC SYNDROME MEAN?

Summary and conclusions. Chapter 8. Summary and conclusions

How To Treat Dyslipidemia

Weight-Loss Surgery for Adults With Diabetes or Prediabetes Who Are at the Lower Levels of Obesity

Nonalcoholic Fatty Liver Disease. Dietary and Lifestyle Guidelines

1333 Plaza Blvd, Suite E, Central Point, OR *

Position Statement Weight Loss Surgery (Bariatric Surgery) and its Use in Treating Obesity or Treating and Preventing Diabetes

Pathogenesis of type 2 diabetes mellitus

Transcription:

Reversing type 2 diabetes: pancreas composition and function during return to normal glucose tolerance Dr Sarah Steven Clinical Research Fellow to Professor Roy Taylor

Observations from bariatric surgery Type 2 diabetes is widely believed to be inevitably progressive However, bariatric surgery can reverse diabetes The reversal of diabetes occurs before any significant weight loss occurs Guidone et al. Diabetes 2006 Could the reversal of diabetes relate to energy restriction alone? 7 weeks of moderate calorie restriction has been shown to be associated with improvement in FPG Petersen et al. Diabetes 2005

Fat and the beta cell Intra-organ fat accumulation is central to the pathophysiology of type 2 diabetes Taylor Diabetologia 2008 The transition from abnormal glucose tolerance to overt type 2 diabetes is determined by a decrease in insulin secretory capacity Clear in vitro evidence that exposure to fatty acid impairs acute insulin release Morgan Curr Opin Clin Nutr Metab Care 2009 The pancreas is the least studied organ in type 2 diabetes

Using MR Spectroscopy to examine pancreas fat 1.9% 6.6% Repeatability is no better than 15% When patient breathes in deeply, visceral fat is included in measurement

New development: the 3 point Dixon MR technique fat fat percentage water

Counterpoint Study Lim et al. Diabetologia 2011; 54 (10):2506-2514 Aims 1) Can a very low calorie diet normalise the abnormalities in the pancreas and liver seen in type 2 diabetes? 2) What is the time course of these changes?

Counterpoint Study 11 subjects with T2DM (BMI 33.6±1.2 kg/m 2 ) and 9 controls 8 week Optifast diet: 600kcal + 3 portions of non-starchy vegetables Metabolic studies at baseline, 1, 4 and 8 weeks of VLCD a) Pancreas: beta cell function using an incremental insulin secretion test b) Liver: insulin sensitivity by isoglycaemic hyperinsulinaemic clamp c) Liver and pancreatic fat levels: 3 point Dixon MR method Follow-up OGTT 3 months after completing diet

Plasma glucose 9.2 ± 0.4 5.9 ± 0.4 mmol/l; p = 0.003 Fasting plasma glucose (mmol/l) 10 8 6 4 0 2 4 6 8 Week

% Insulin suppression of HGP 100 80 60 40 20 CON: 68 ± 5% DM: 43 ± 4% (p = 0.001) Marked after 1 week of diet (74 ± 5%, p = 0.003) 0 Week 0 Week 1 Week 4 Week 8 20 Liver fat content (%) 15 10 5 0 Week 0 Week 1 Week 4 Week 8 CON: 8.5 ± 1.9% DM: 12.8 ± 2.4% Reduced by 30% during 1 st week; 70% by 8 weeks

Insulin secretion rates Normal controls c 1.8 1.5 Diabetes: Baseline T2DM - baseline ISR (nmol/min/m 2 ) 1.2 0.9 0.6 0.3-20 0 20 40 60 80 Time (min) T2DM - Week 1 T2DM - Week 8

First phase insulin response (nmol/min/m 2 ) Pancreas fat content (%) 1.0 0.8 0.6 0.4 0.2 0.0 12 9 6 3 0 2 4 6 8 0 2 4 6 8 0 2 4 6 8 Week Insulin secretion steadily At 8 weeks, similar to control values Pancreatic fat content fell gradually over 8 weeks

Follow-up 3 month follow-up after general lifestyle advice Mean weight gain 3.1 ± 1 kg Fasting plasma glucose 6.1 ± 0.2 mmol/l 3 1 4 IGT 3 NGT T2D Unavailable

Aetiology of Type 2 Diabetes: Twin Cycle Hypothesis Positive calorie balance ++ Pre-existing insulin resistance liver fat Liver cycle Resistance to insulin suppression of HGP VLDL triglyceride basal insulin secretion plasma glucose Pancreas cycle islet triglyceride acute insulin response to food Taylor, Diabetologia 2008

Translation to clinical practice Worldwide public interest in the diet Information for people with diabetes and healthcare practitioners provided via website Feedback of personal experiences: - 70 individuals with T2DM: 59M, 11F - Diabetes reversal: 57%

Metabolic effects of calorie restriction 4 days post RYGB or post bypass diet Weight loss RYGB 1.4 ± 5.3kg 1 ± 3.4% Post-bypass diet 2.2 ± 1kg 2.2 ± 1% Fasting glucose -6% -20% Insulin levels -25% -27% HOMA-IR -25% -30% Isbell et al. Diabetes Care 2010 7-10% weight loss following RYGB (3.4 weeks) and LCD (8.1 weeks) Plum et al. Obesity 2011 7 day VLCD in T2DM with BMI>40kg/m 2 : 3.58kg weight loss, FPG 7.66 to 6.9mmol/l Malandrucco et al. Am J Clin Nutr 2012

Hypothesis of PANCREAS study The changes in the pancreas and liver that underlie the normalisation of blood glucose after bariatric surgery are the same as those that occur after a very low calorie diet

Specific aims To compare the effect of bariatric surgery with that of very low calorie diet upon fasting plasma glucose, beta cell response to glucose and pancreatic fat content, liver insulin sensitivity and liver fat content To examine whether secretion of incretin hormones changes principally in response to change in calorie intake or as a specific response to bariatric surgery

Protocol 1 2 3 Usual presurgery diet VLCD Post-surgery diet 18 subjects with T2D 1 2 3 Usual pre-surgery diet Postsurgery diet Post-surgery diet 1 2 10 nondiabetic weight matched Usual pre-surgery diet Post-surgery diet Weeks -2-1 Surgery +1 +8

Expected outcomes Improve our understanding of how diabetes can be reversed Develop acceptable and durable non-surgical approaches to the reversal of type 2 diabetes Allow further developmental work on the technique to accurately image the pancreas